The field of healthcare is currently facing alarming challenges on multiple fronts, with recent studies providing insight into these pressing issues. One such concern is the escalating prevalence of multidrug-resistant (MDR) pathogens in hospital settings. A study conducted by researchers from Al-Quds University analyzed 10,007 unique bacterial samples from 13 government hospitals in the West…
Healthcare-associated infections (HAIs) and multidrug-resistant (MDR) pathogens pose significant threats to global health. Challenges associated with these threats have intensified with the rise of SARS-CoV-2 and an expanding immunocompromised population. Isolation precautions form a critical part of infection prevention control (IPC) strategies, but their arbitrary usage can strain resources and impede patient well-being, necessitating a…
In 2024, the Asia Pacific hospital-acquired disease testing market size was valued at USD 3.19 billion, a figure predicted to rise to a significant USD 11.51 billion by 2033, highlighting a promising Compound Annual Growth Rate (CAGR) of 15.32%. This exciting growth is propelled by the rising necessity for precise and swift diagnostic procedures capable…
Amid the persistent global health challenges posed by antimicrobial resistance, multidrug-resistant and Extended-Spectrum β-Lactamase producing-Enterobacterales (ESBL-E) have emerged as critical public health pathogens. These microorganisms demand urgent research and the development of new drugs.
A study centered in the West region of Cameroon sought to identify the prevalence of these pathogens and the specific genes bestowing…